A new human papillomavirus (HPV) vaccine that protects against nine types of HPV and would protect against about 90% of cervical cancers could be available in 2015.
Challenge your diagnostic skills with these images of a pelvic mass.
Adding the TKI cediranib to chemotherapy improved progression-free survival in patients with metastatic or relapsed cervical cancer, according to a study presented at the 2014 ESMO Congress.
Urine tests effectively screen for HPV, but more data is needed to determine whether they can correctly diagnose cervical disease.
Look no further: The North American Menopause Society has issued recommendations that offer the latest information for managing a woman's health through menopause.
Exposure to two common phenols, parabens and triclosans, may disrupt the growth of boys in utero and during their first years of life.
Are women with early-stage unilateral breast cancer misinformed about the survival benefit of removing both breasts vs lumpectomy with radiation?
Just in case your patients ever ask, wearing a bra is in no way associated with breast cancer risk.
Be it Pap tests, HPV tests, or both, cervical cancer screening is important. This article explores screening paradigms and offers a glimpse of what's to come.
The FDA has approved bevacizumab (Avastin) for treating persistent, recurrent, or metastatic cervical cancer after studies show gains in overall survival.